Content about Aciclovir

May 3, 2013

Actavis sales up 24% in first quarter 2013

Actavis' had $1.9 billion in sales in first quarter 2013, the drug maker said.

April 5, 2013

Actavis to market, distribute authorized generic version of Valeant drug; Valeant to co-promote Actavis drug

Actavis will market and distribute an authorized generic version of a genital herpes ointment made by Valeant Pharmaceuticals International, the companies said Friday.

April 4, 2013

Valeant earnings per share could take hit in 2013 from herpes ointment generic

The Food and Drug Administration approval this week of a generic genital herpes ointment made by Mylan could make a slight dent in the stock price of the company that makes the branded version.

April 3, 2013

FDA approves Mylan genital herpes ointment

The Food and Drug Administration has approved a new drug for genital herpes made by Mylan, the drug maker said.

March 24, 2011

Actavis' generic Valtrex OKed by FDA

The Food and Drug Administration has approved a generic treatment for shingles and genital herpes made by Actavis, the drug maker said Wednesday.

March 1, 2011

Cold sore treatment Xerese enters market

Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

February 3, 2011

Valeant receives U.S., Canadian rights for Zovirax

Drug maker Valeant Pharmaceuticals International has acquired U.S. and Canadian rights to certain formulations of a GlaxoSmithKline drug used to treat cold sores.

June 23, 2010

GSK licenses OTC Xerclear; U.S. market excluded

GlaxoSmithKline on Wednesday announced an exclusive agreement for the over-the-counter rights to Medivir’s cold sore...

June 9, 2010

Roxane gets nod for generic herpes treatment

The Food and Drug Administration has approved a generic version of a drug for herpes...

May 24, 2010

Generic Valtrex to hit the market

Teva Pharmaceuticals has introduced a generic version of a drug for genital herpes, shingles and...

February 17, 2010

Meda, Medivir to develop, commercialize cold-sore drug

Meda plans to work with Medivir to commercialize a cold-sore drug in North America, the...